SCHWIND eye-tech-solutions GmbH
Simon Narwutsch has a diverse work experience in the fields of regulatory affairs, teaching, and neurolinguistics. Simon is currently the Head of Regulatory Affairs at SCHWIND eye-tech-solutions GmbH since September 2023. Prior to this, they worked as a Dozent at Universitätsklinikum Heidelberg (UKHD) from February 2019 to September 2023 and at SRH Hochschule für Gesundheit from April 2019 to July 2021. Simon also has experience in regulatory affairs at DeviceMaster GmbH from April 2021 to June 2023. Simon previously worked as a Neurolinguist at Caritas Trägergesellschaft Saarbrücken mbH (cts) from July 2018 to March 2021.
Simon Narwutsch completed their education in a specific chronological order. Simon first attended the University of Vienna from 2010 to 2013, where they pursued a Bachelor of Arts degree in Sprachwissenschaften.
Afterward, they enrolled at Paris Lodron Universität Salzburg, where they earned a Master of Science degree in Neurolinguistik from 2014 to 2018.
In the year 2020, Simon Narwutsch pursued further education at the Regierungspräsidium des Landes Baden-Württemberg, acquiring a Staatliche Anerkennung in Logopädie within the same year.
Aside from their academic achievements, Simon Narwutsch also attained additional certifications. Simon obtained the title of "MDR Expert" from TÜV Süd in July 2022. Furthermore, they acquired the qualification of "Manager Regulatory Affairs" from the same institution in December 2021.
This person is not in any offices
SCHWIND eye-tech-solutions GmbH
SCHWIND eye-tech-solutions is one of the technology leaders in refractive corneal surgery. The medium-sized company with headquarter in Germany provides a comprehensive product portfolio that help patients achieve spectacle independence and that can also be used to treat corneal diseases. SCHWIND stands as a pioneer in the refractive market, driving advanced solutions for vision correction procedures and building strong relationships with customers with one common goal in mind: to improve the lives of those with vision deficiencies. Whether Berlin or Bogota, Jakarta, London or Sydney, eye surgeons in more than 100 countries treat their patients using SCHWIND laser systems. The SCHWIND AMARIS excimer and SCHWIND ATOS femtosecond laser systems cover an outstanding broad range of applications, from PRK, TransPRK (i.e. SmartSurfACE), LASEK, FemtoLASIK, PTK, TransPTK, CXL, and keratoplasty with the AMARIS product family to LASIK flap and lenticule extraction (i.e. SmartSight) with the ATOS. Another key differentiator is, that SCHWIND diagnostic devices are seamlessly integrated in the laser environment. About ten million treatments have been performed with the SCHWIND laser systems so far. Imprint: https://www.eye-tech-solutions.com/imprint Privacy Policy: https://www.eye-tech-solutions.com/privacy Imprint and privacy policy apply to both, our website and our LinkedIn profile as well.